Implication of CXCL5 epithelial neutrophilactivating peptide 78 in the development of insulin resistance in patients with rheumatoid arthritis

Simple item page
dc.citation.doiN/A
dc.citation.epage379
dc.citation.spage373
dc.contributor.authorB Tejera-Segura
dc.contributor.authorR Lopez-Mejias
dc.contributor.authorA de Vera-Gonzalez
dc.contributor.authorA Gonzalez-Delgado
dc.contributor.authorMiguel Gonzalez-Gay
dc.contributor.authorI Ferraz-Amaro
dc.date.accessioned2023-04-13T10:57:01Z
dc.date.available2023-04-13T10:57:01Z
dc.identifier.citationISI
dc.identifier.issn0392-856X
dc.identifier.urihttps://hdl.handle.net/10539/35071
dc.journal.titleCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
dc.journal.volume37
dc.titleImplication of CXCL5 epithelial neutrophilactivating peptide 78 in the development of insulin resistance in patients with rheumatoid arthritis
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal.pdf
Size:
230.14 KB
Format:
Adobe Portable Document Format
Description:
Journal
Download
Collections
Wits Research Outputs